Ronald M. Evans,Michael Downes,Zong Wei,Annette Atkins,Ruth T. Yu
申请号：
US16737312
公开号：
US20200129532A1
申请日:
2020.01.08
申请国别(地区):
US
年份:
2020
代理人:
摘要：
Methods are provided for reducing blood glucose, which utilize an agent that increases the biological activity of a vitamin D receptor (VDR) (e.g., a VDR agonist), in combination with an antagonist of bromodomain-containing protein 9 (BRD9). IN some examples, such methods treat type II diabetes.
